v3.26.1
Condensed Consolidated Statement of Changes in Mezzanine Equity and Stockholders' Equity (Unaudited) - USD ($)
Series K Preferred Stock [Member]
Temporary Equity [Member]
Series J Preferred Stock [Member]
Temporary Equity [Member]
Series I Preferred Stock [Member]
Temporary Equity [Member]
Series H-7 Preferred Stock [Member]
Temporary Equity [Member]
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 7,587,518 $ 53 $ 121,767,394 $ (117,085,518) $ 4,681,929
Balance, shares at Dec. 31, 2024 10,167 8 1,234 50 533,842      
Deemed dividend (338,915) (338,915)
Preferred stock dividends 494,818 (494,818) (494,818)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock 1,686,854 (1,686,854) (1,686,854)
Net income (loss) 845,011 845,011
Preferred stock redemptions and conversion including cash premium $ (6,404,587)
Preferred stock redemptions and conversions including cash premium, shares       (5,500)              
Balance at Mar. 31, 2025 $ 3,364,603 $ 53 119,246,807 (116,240,507) 3,006,353
Balance, shares at Mar. 31, 2025 4,667 8 1,234 50 533,842      
Balance at Dec. 31, 2024 $ 7,587,518 $ 53 121,767,394 (117,085,518) 4,681,929
Balance, shares at Dec. 31, 2024 10,167 8 1,234 50 533,842      
Net income (loss)                     (13,298,007)
Balance at Jun. 30, 2025 $ 59 117,278,388 (130,383,525) (13,105,078)
Balance, shares at Jun. 30, 2025 8 1,234 50 590,181      
Balance at Mar. 31, 2025 $ 3,364,603 $ 53 119,246,807 (116,240,507) 3,006,353
Balance, shares at Mar. 31, 2025 4,667 8 1,234 50 533,842      
Deemed dividend (323,636) (323,636)
Preferred stock dividends 546,825 (546,825) (546,825)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock 1,562,047 (1,562,047) (1,562,047)
Net income (loss) (14,143,018) (14,143,018)
Stock based compensation 69,480 69,480
Preferred stock redemptions and conversion including cash premium $ (5,473,475) $ 6 394,609 394,615
Preferred stock redemptions and conversions including cash premium, shares       (4,667)       56,215      
Issuance of round up shares
Issuance of round up shares, shares               124      
Balance at Jun. 30, 2025 $ 59 117,278,388 (130,383,525) (13,105,078)
Balance, shares at Jun. 30, 2025 8 1,234 50 590,181      
Balance at Dec. 31, 2025 $ 4,451,040 $ 1,551,232 $ 146 141,884,878 (138,174,663) 3,710,361
Balance, shares at Dec. 31, 2025 7,000 1,180 8 1,234 50 1,455,975      
Deemed dividend $ (252,509) $ (151,024)
Preferred stock dividends 190,987 (24,316) (166,671) (166,671)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock 941,478 (941,478) (941,478)
Issuance of consultant warrants 992,576 992,576
Net income (loss) (2,414,475) (2,414,475)
Balance at Mar. 31, 2026 $ 5,330,996 $ 1,375,892 $ 146 141,769,305 (140,589,138) 1,180,313
Balance, shares at Mar. 31, 2026 7,000 1,180 8 1,234 50 1,455,975      
Balance at Dec. 31, 2025 $ 4,451,040 $ 1,551,232 $ 146 141,884,878 (138,174,663) 3,710,361
Balance, shares at Dec. 31, 2025 7,000 1,180 8 1,234 50 1,455,975      
Net income (loss)                     (14,896,507)
Balance at Jun. 30, 2026 $ 11,110,676 $ 5,636,020 $ 417,833 $ 666 164,236,279 (153,071,170) 11,165,775
Balance, shares at Jun. 30, 2026 21,500 3,810 300 8 1,234 50 6,663,912      
Balance at Mar. 31, 2026 $ 5,330,996 $ 1,375,892 $ 146 141,769,305 (140,589,138) 1,180,313
Balance, shares at Mar. 31, 2026 7,000 1,180 8 1,234 50 1,455,975      
Preferred stock dividends $ 259,194 $ 29,566 $ 49,913 $ 15,241 (353,912) (353,912)
Issuance of consultant warrants 1,105,781 1,105,781
Net income (loss) (12,482,032) (12,482,032)
Stock based compensation 848,546 848,546
Issuance of convertible preferred stock, net of discounts and transaction costs $ 10,851,482 $ 5,606,454 8,864,064 8,864,064
Issuance of convertible preferred stock, net of discounts and transaction costs, shares 21,500 3,810                  
Preferred stock redemptions and conversion including cash premium $ (6,442,529) $ (1,389,654) $ 320 7,831,862 7,832,182
Preferred stock redemptions and conversions including cash premium, shares     (6,700) (1,180)       3,204,291      
Accretion of discounts to redemption value of Series I convertible preferred stock $ 1,748,453 (1,748,453) (1,748,453)
Common stock issued for exercise of Series H-7 Preferred warrants $ 118 2,961,800 2,961,918
Common stock issued for exercise of Series H-7 Preferred warrants, shares               1,180,000      
Common stock issued for exercise of Series I Preferred warrants $ 82 2,067,269 2,067,351
Common stock issued for exercise of Series I Preferred warrants, shares               823,646      
Amendment modification (269,000) (1,479) 163,479 163,479
Warrant modification (838,462) (838,462)
Issuance of Series H-7 and Series I waiver warrants 1,565,000 1,565,000
Balance at Jun. 30, 2026 $ 11,110,676 $ 5,636,020 $ 417,833 $ 666 $ 164,236,279 $ (153,071,170) $ 11,165,775
Balance, shares at Jun. 30, 2026 21,500 3,810 300 8 1,234 50 6,663,912